☆ 4.5 Review

The vinyl sulfone motif as a structural unit for novel drug design and discovery

EXPERT OPINION ON DRUG DISCOVERY (2023)

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)

Marketa Kovalova et al.

Summary: CDK7 is a protein kinase that regulates the cell cycle and mRNA transcription, and it has emerged as a potential drug target in oncology. Six promising drug candidates have been evaluated in early clinical trials. This review analyzes patents published from 2018 to 2022 and provides an overview of CDK7 inhibitors as anticancer drugs, including their chemical structures, biochemical profiles, and developmental stages.

EXPERT OPINION ON THERAPEUTIC PATENTS (2023)

Add to Collection
Review Chemistry, Medicinal

A patent review of selective CDK9 inhibitors in treating cancer

Tizhi Wu et al.

Summary: The dysregulation of CDK9 protein is closely associated with the proliferation and differentiation of various cancers, and targeting CDK9 is considered a promising strategy for antitumor drug development. The development of selective CDK9 inhibitors has gained increasing attention due to the potential side effects of pan-CDK9 inhibitors.

EXPERT OPINION ON THERAPEUTIC PATENTS (2023)

Add to Collection
Review Pharmacology & Pharmacy

Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)

Ana Monfort-Vengut et al.

Summary: Rigosertib is a small-molecule compound currently in phase III clinical trials for the treatment of various myelodysplastic syndromes and leukemias. However, its clinical progress has been hindered by a lack of understanding of its mechanism of action.

PHARMACEUTICS (2023)

Add to Collection
Article Chemistry, Medicinal

Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum

John M. Bennett et al.

ACS Infectious Diseases (2023)

Add to Collection
Editorial Material Oncology

A single inhibitor for all KRAS mutations

Ryan B. Corcoran

Summary: The recent development of a first-in-class pan-KRAS-selective inhibitor, which has received FDA approval, is a significant breakthrough in KRAS-targeting approaches. A study published in Nature provides insights into the current status of this field.

NATURE CANCER (2023)

Add to Collection
Article Biochemistry & Molecular Biology

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

Ioanna Deni et al.

Summary: This study found that vinyl sulfone inhibitors are effective against artemisinin-resistant parasites and do not readily develop resistance. Additionally, resistance to one inhibitor can increase sensitivity to other types of inhibitors. These findings suggest that dual targeting of different proteasome subunits using covalent inhibitors may be a potential strategy for restoring artemisinin activity and combating drug-resistant malaria spread.

CELL CHEMICAL BIOLOGY (2023)

Add to Collection
Article Chemistry, Medicinal

Exploration of BAY 11-7082 as a Potential Antibiotic

Victoria E. Coles et al.

Summary: In this study, exposure of Gram-negative pathogen Pseudomonas aeruginosa to subinhibitory concentrations of antibiotics led to increased biofilm formation. A biofilm-based high-throughput screen was used to identify molecules with potential antimicrobial activity, and the anti-inflammatory compound BAY 11-7082 was found to have antibacterial activity. Further experiments confirmed its inhibitory effects on P. aeruginosa and other priority pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Analogs of BAY 11-7082 were synthesized, and some displayed enhanced activity against Staphylococcus aureus. The study also identified minor differences in the structure-activity relationship for the anti-inflammatory and antibacterial properties of the compound. It was observed that BAY 11-7082 and its analogs synergized with penicillin G against MRSA, suggesting their potential use as antibiotic adjuvants.

ACS INFECTIOUS DISEASES (2022)

Add to Collection
Article Chemistry, Medicinal

Antibacterial activity evaluation of vinyl sulfones against global predominant methicillin-resistant Staphylococcus aureus USA300

Onanong Vorasin et al.

Summary: The study identified a range of potential antibacterial vinyl sulfone derivatives, with nitrile-substituted vinyl phenyl sulfones showing the strongest activity and potentially functioning through sulfhydryl conjugation. Additionally, these compounds could also affect host cell adhesion, suggesting promising therapeutic potential for S. aureus and MRSA.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Add to Collection
Review Chemistry, Medicinal

Recent applications of vinyl sulfone motif in drug design and discovery

Reza Ahmadi et al.

Summary: Vinyl sulfone is an important organic compound with a unique chemical structure, playing a significant role in drug discovery and development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection
Article Chemistry, Medicinal

A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors

Laszlo Petri et al.

Summary: In this study, a covalent design strategy targeting intrinsically disordered proteins (IDPs) was developed based on the promising results of targeted covalent inhibitors (TCIs) on challenging targets. Using tau protein as a model system, suitable warheads were introduced to non-covalent scaffolds of potential tau aggregation inhibitors. The designed covalent tau binders effectively inhibited tau aggregation in aggregation models, providing promising candidates for the treatment of tauopathies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection
Article Chemistry, Medicinal

(E)-β-Trifluoromethyl vinylsulfones as antitumor agents: Synthesis and biological evaluations

Jun Zhang et al.

Summary: A three-component reaction was developed to synthesize various trifluoromethyl-substituted vinyl sulfones with excellent stereoselectivity. Palladium-catalyzed amination was utilized for further modification of these compounds. The antitumor mechanism of these trifluoromethyl-substituted vinyl sulfones in cytotoxic autophagy induced by PI3K/Akt/mTOR signal was investigated.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection
Review Pharmacology & Pharmacy

The importance of sulfur-containing motifs in drug design and discovery

Muhamad Mustafa et al.

Summary: Sulfur-containing functional groups play a significant role in medicinal chemistry and drug discovery. They have diverse applications and are found in a wide range of pharmacologically effective substances. The study reviews the recent research on organosulfur-based drug discovery and highlights the potential of sulfur-based compounds in lead compound development. Despite the growing importance of sulfur in medicinal chemistry, there is still a need for further exploration and development of synthetic methodologies for these functional groups.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Add to Collection
Editorial Material Immunology

High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine

Judith Straimer et al.

Summary: Mutations in the Plasmodium falciparum K13 gene have caused treatment failures in malaria patients receiving artemisinin combination therapies in Southeast Asia. Until recently, relevant K13 mutations had been mostly absent from Africa. A phase 2 clinical study in Mali, Gabon, Ghana, Uganda, and Rwanda reported a 22% allele frequency for R561H in Rwanda and associated delayed parasite clearance.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection
Article Chemistry, Medicinal

The Ascension of Targeted Covalent Inhibitors

Juswinder Singh

Summary: Covalent drugs have had a significant impact on human health, but they were previously avoided by the pharmaceutical industry due to concerns about potential toxicity. However, there has been a resurgence in interest with the clinical success of targeted covalent inhibitors (TCIs) and the approval of eight drugs in the past decade. The ability to create unique drugs through the covalent mechanism of action has led to clinically decisive target product profiles. TCIs have revolutionized the treatment approach for non-small-cell lung cancer and chronic lymphocytic leukemia. This Perspective article highlights the clinical and financial success of this drug class and provides early insights into toxicity, a previously hindering factor in the field.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection
Review Chemistry, Medicinal

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies

Sibel Suzen et al.

Summary: Neurodegenerative diseases are characterized by high levels of oxidative stress biomarkers and low levels of antioxidant protection; Dysregulation of the oxidant/antioxidant balance is a major factor in the pathogenesis of these diseases; Nrf2 plays a protective and defending role against neurodegenerative conditions.

PHARMACEUTICALS (2022)

Add to Collection
Article Chemistry, Organic

Design, synthesis and biological evaluation of phenyl vinyl sulfone based NLRP3 inflammasome inhibitors

Xiangna Zhang et al.

BIOORGANIC CHEMISTRY (2022)

Add to Collection
Review Oncology

The current state of the art and future trends in RAS-targeted cancer therapies

Salman R. Punekar et al.

Summary: Despite being historically considered 'undruggable', improvements in drug design have led to the development of inhibitors that target KRAS mutations in solid tumors. Some of these inhibitors have shown efficacy in patients with KRAS (G12C)-mutant cancers, but drug resistance limits their effectiveness. However, there is potential for novel combination therapies, which are currently being explored in clinical trials, to overcome resistance mechanisms. This article provides an overview of the RAS pathway and reviews the current strategies for targeting oncogenic RAS, as well as the challenges presented by drug resistance mechanisms.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Add to Collection
Review Biotechnology & Applied Microbiology

Advances in covalent drug discovery

Lydia Boike et al.

Summary: Covalent drugs have been widely used for over a century, but recent advances in tools for rational design have led to the successful development of potent and selective inhibitors, such as KRAS(G12C) inhibitors. The use of electrophile-first approaches and the emergence of chemoproteomics platforms have greatly enhanced the discovery and development of covalent drugs.

NATURE REVIEWS DRUG DISCOVERY (2022)

Add to Collection
Article Chemistry, Organic

Development of on-DNA vinyl sulfone synthesis for DNA-encoded chemical libraries

Yuting Gao et al.

Summary: The DNA-encoded chemical library (DEL) technology, with the incorporation of vinyl sulfone, enables mild and efficient DNA-compatible synthesis, demonstrating the feasibility of DEL construction.

ORGANIC CHEMISTRY FRONTIERS (2022)

Add to Collection
Review Oncology

Targeting CDK4 and CDK6 in cancer

Shom Goel et al.

Summary: Dysregulation of CDK4 and CDK6 promotes the growth and survival of several cancer types. CDK4/6 inhibitors have become the standard of care for advanced hormone receptor-positive breast cancer. Better understanding of their mechanisms of action and exploring new therapeutic opportunities are crucial.

NATURE REVIEWS CANCER (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Microtubule associated proteins as targets for anticancer drug development

Sadiya Khwaja et al.

Summary: The dynamic equilibrium of tubulin-microtubule is crucial for cell survival, making it an important target for cancer drug development. Microtubules play essential roles in mitosis and cell multiplication, while MAPs interact with microtubules to affect their stability. Post-translational modifications of lysine-40 and HDAC inhibitors have significant roles in gene expression and anticancer properties, respectively.

BIOORGANIC CHEMISTRY (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Identification of highly selective covalent inhibitors by phage display

Shiyu Chen et al.

Summary: A phage display method was developed to screen for covalent inhibitors that bind to protein targets by introducing a reactive linker to form cyclic peptides and an electrophilic 'warhead' to react with target nucleophiles. This approach identified cyclic peptides that irreversibly inhibited cysteine protease and serine hydrolase with high specificity and potency. It enables rapid, unbiased screening to identify new classes of highly selective covalent inhibitors for diverse molecular targets.

NATURE BIOTECHNOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection

Zi-Long Song et al.

Summary: Oxidative stress plays a role in the development of neurodegenerative diseases, and targeting oxidative stress is a promising strategy for treatment. Small molecules that interfere with cellular redox-regulating machinery, such as compounds 9b and 9c, show neuroprotective effects by upregulating antioxidant genes through the Nrf2 pathway, making them potential candidates for further development as neuroprotective agents.

BIOORGANIC CHEMISTRY (2021)

Add to Collection
Article Chemistry, Medicinal

Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease

Ji Won Choi et al.

Summary: The synthesized compound 9d showed superior Nrf2 activation efficacy, significantly affecting Nrf2 nuclear translocation and protein levels in microglial BV-2 cells, inducing the expression of antioxidant response genes, and reducing the expression of proinflammatory cytokines and enzymes.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Drake M. Mellott et al.

Summary: K777, an irreversible inactivator of cysteine proteases, has shown reduction in the infectivity of SARS-CoV-2 in various host cells. By inhibiting the activity of host cathepsin L, this drug prevents the processing of viral spike protein, thereby reducing viral infectivity.

ACS CHEMICAL BIOLOGY (2021)

Add to Collection
Article Infectious Diseases

Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study

Aline Uwimana et al.

Summary: This study confirms the emergence of artemisinin partial resistance in Rwanda. Although artemether-lumefantrine remains efficacious, vigilance for decreasing efficacy and further characterization of artemisinin partial resistance should be considered. Evaluation of additional antimalarials in Rwanda is also recommended.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies

Thitinan Aiebchun et al.

Summary: In this study, a series of designed vinyl sulfone derivatives were screened for inhibitory activity against EGFR-TK, with VF16 compound showing promising inhibitory activity and high cytotoxicity against multiple cancer cell lines. Molecular dynamics simulations suggested that VF16 could be a novel small molecule inhibitor targeting EGFR-TK.

MOLECULES (2021)

Add to Collection
Review Biotechnology & Applied Microbiology

Kinase drug discovery 20 years after imatinib: progress and future directions

Philip Cohen et al.

Summary: Advances in improving the potency and specificity of small-molecule protein kinase inhibitors over the past 20 years have had a significant impact on the treatment of cancers and non-cancerous conditions. Efforts are being made to address the challenge of drug resistance to kinase inhibitors, and future directions in kinase drug discovery are being discussed.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection
Review Biotechnology & Applied Microbiology

Trends in kinase drug discovery: targets, indications and inhibitor design

Misty M. Attwood et al.

Summary: The article analyzes the landscape of approved and investigational therapies that target kinases, highlighting the increasing importance of kinase inhibitors in oncology and beyond. It discusses trends in kinase inhibitor design and points out that there are still substantial unexplored opportunities for this drug class.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection
Review Neurosciences

NRF2 as a Therapeutic Target in Neurodegenerative Diseases

Mikah S. Brandes et al.

ASN NEURO (2020)

Add to Collection
Article Chemistry, Medicinal

Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine

Guangyan Du et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection
Article Chemistry, Medicinal

Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities

Huaisheng Zhang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Add to Collection
Review Biochemistry & Molecular Biology

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases

Angel Cores et al.

BIOMOLECULES (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda

Aline Uwimana et al.

NATURE MEDICINE (2020)

Add to Collection
Article Chemistry, Medicinal

Vinyl Sulfone-Based Inhibitors of Nonstructural Protein 2 Block the Replication of Venezuelan Equine Encephalitis Virus

Huaisheng Zhang et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Add to Collection
Article Chemistry, Medicinal

Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics

Hao Chen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site

Wenlong Li et al.

BIOORGANIC CHEMISTRY (2019)

Add to Collection
Article Chemistry, Medicinal

Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability

Ying Chen et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection
Article Chemistry, Medicinal

Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator

Ji Won Choi et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Add to Collection
Article Chemistry, Medicinal

Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections

Gao-Feng Zha et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection
Article Chemistry, Medicinal

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

Matthias Gehringer et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection
Article Chemistry, Medicinal

Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy

Ji Won Choi et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection
Article Chemistry, Medicinal

Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent

Huaisheng Zhang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Add to Collection
Review Biotechnology & Applied Microbiology

Targeting the NLRP3 inflammasome in inflammatory diseases

Matthew S. J. Mangan et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Add to Collection
Article Multidisciplinary Sciences

Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes

David S. Hewings et al.

NATURE COMMUNICATIONS (2018)

Add to Collection
Review Chemistry, Multidisciplinary

Analysis of US FDA-Approved Drugs Containing Sulfur Atoms

Kevin A. Scott et al.

TOPICS IN CURRENT CHEMISTRY (2018)

Add to Collection
Article Chemistry, Medicinal

Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities

Wenlong Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection
Article Chemistry, Multidisciplinary

A Vinyl Sulfone-Based Fluorogenic Probe Capable of Selective Labeling of PHGDH in Live Mammalian Cells

Sijun Pan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Add to Collection
Article Biochemistry & Molecular Biology

Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent

Marco Jost et al.

MOLECULAR CELL (2017)

Add to Collection
Review Biochemistry & Molecular Biology

NF-kappa B signaling in inflammation

Ting Liu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)

Add to Collection
Review Chemistry, Multidisciplinary

Lysine-Targeting Covalent Inhibitors

Jonathan Pettinger et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

Add to Collection
Article Biochemistry & Molecular Biology

Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson's disease

Xianling Ning et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)

Add to Collection
Review Chemistry, Multidisciplinary

Targeted Covalent Inhibitors for Drug Design

Thomas A. Baillie

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Add to Collection
Article Chemistry, Medicinal

Synthesis and biological evaluation of heteroaryl styryl sulfone derivatives as anticancer agents

Yi Long et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Add to Collection
Article Biochemistry & Molecular Biology

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

Sai Krishna Athuluri-Divakar et al.

CELL (2016)

Add to Collection
Article Multidisciplinary Sciences

Structure- and function-based design of Plasmodium-selective proteasome inhibitors

Hao Li et al.

NATURE (2016)

Add to Collection
Review Biotechnology & Applied Microbiology

Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design

Jonathan M. L. Ostrem et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Add to Collection
Article Biochemistry & Molecular Biology

Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile

Upendra P. Dahal et al.

MEDCHEMCOMM (2016)

Add to Collection
Article Oncology

ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines

Anil Prasad et al.

ONCOTARGET (2016)

Add to Collection
Review Pharmacology & Pharmacy

Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets

Sonia Verma et al.

FRONTIERS IN PHARMACOLOGY (2016)

Add to Collection
Meeting Abstract Hematology

Safety, Efficacy, and Pharmacokinetic Profiles of Intravenous Rigosertib in Japanese Patients with Recurrent/Relapsed or Refractory Myelodysplastic Syndromes: A Multicenter, Open-Label Phase I Clinical Study

Michinori Ogura et al.

BLOOD (2016)

Add to Collection
Review Chemistry, Multidisciplinary

Recent advances in the synthesis of vinyl sulfones

Yuyu Fang et al.

RSC ADVANCES (2016)

Add to Collection
Article Pharmacology & Pharmacy

Protease inhibitors targeting coronavirus and filovirus entry

Yanchen Zhou et al.

ANTIVIRAL RESEARCH (2015)

Add to Collection
Article Biochemistry & Molecular Biology

Identification and Characterization of an Irreversible Inhibitor of CDK2

Elizabeth Anscombe et al.

CHEMISTRY & BIOLOGY (2015)

Add to Collection
Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread

Yi Shen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Add to Collection
Review Oncology

Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response

Oakley C. Olson et al.

NATURE REVIEWS CANCER (2015)

Add to Collection
Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of (E)-3,4-Dihydroxystyryl Aralkyl Sulfones and Sulfoxides as Novel Multifunctional Neuroprotective Agents

Xianling Ning et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection
Article Chemistry, Medicinal

Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure-Activity Relationships, and Biological Activities

Tiangong Lu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection
Article Chemistry, Medicinal

Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson's Disease Therapy

Seo Yeon Woo et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection
Article Biochemistry & Molecular Biology

Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury

Xianling Ning et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Add to Collection
Article Chemistry, Medicinal

An Endoperoxide-Based Hybrid Approach to Deliver Falcipain Inhibitors Inside Malaria Parasites

Rudi Oliveira et al.

CHEMMEDCHEM (2013)

Add to Collection
Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of (E)-N-Aryl-2-arylethenesulfonamide Analogues as Potent and Orally Bioavailable Microtubule-Targeted Anticancer Agents

M. V. Ramana Reddy et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Add to Collection
Article Multidisciplinary Sciences

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

Jonathan M. Ostrem et al.

NATURE (2013)

Add to Collection
Article Multidisciplinary Sciences

ON01210.Na (Ex-RAD®) Mitigates Radiation Damage through Activation of the AKT Pathway

Anthony D. Kang et al.

PLOS ONE (2013)

Add to Collection
Article Polymer Science

Relative reactivity and selectivity of vinyl sulfones and acrylates towards the thiol-Michael addition reaction and polymerization

Shunsuke Chatani et al.

POLYMER CHEMISTRY (2013)

Add to Collection
Article Chemistry, Medicinal

Synthesis, antimicrobial and cytotoxic activities of sulfone linked bis heterocycles

A. Muralikrishna et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Add to Collection
Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel (E)-α-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors

Qing-Shan Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Add to Collection
Article Biology

Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD® in mice

Sanchita P. Ghosh et al.

JOURNAL OF RADIATION RESEARCH (2012)

Add to Collection
Article Cell Biology

BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple Targets

Jaehwi Lee et al.

MEDIATORS OF INFLAMMATION (2012)

Add to Collection
Article Biochemistry & Molecular Biology

Aza vinyl sulfones: Synthesis and evaluation as antiplasmodial agents

Paulo M. C. Gloria et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Add to Collection
Article Chemistry, Medicinal

Synthesis and biological evaluation of benzyl styrylsulfonyl derivatives as potent anticancer mitotic inhibitors

Osama Chahrour et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Add to Collection
Article Chemistry, Medicinal

Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (E)-2-{2-Methoxy-5-[(2′,4′,6′-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure-Activity Relationship, and Biological Activity

M. V. Ramana Reddy et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Add to Collection
Article Biochemistry & Molecular Biology

Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome

Christine Juliana et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Add to Collection
Article Chemistry, Organic

Vinyl sulfone: a versatile function for simple bioconjugation and immobilization

Julia Morales-Sanfrutos et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2010)

Add to Collection
Article Biology

Radiation Protection by a New Chemical Entity, Ex-Rad™: Efficacy and Mechanisms

Sanchita P. Ghosh et al.

RADIATION RESEARCH (2009)

Add to Collection
Article Chemistry, Medicinal

Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents

M. V. Ramana Reddy et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Add to Collection
Article Chemistry, Medicinal

Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors

Roberta Ettari et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Add to Collection
Article Microbiology

A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection

Patricia S. Doyle et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)

Add to Collection
Article Chemistry, Medicinal

Vinyl sulfones: Synthetic preparations and medicinal chemistry applications

D. Christopber Meadows et al.

MEDICINAL RESEARCH REVIEWS (2006)

Add to Collection
Article Microbiology

A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi

SC Barr et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Add to Collection
Article Oncology

ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent

K Gumireddy et al.

CANCER CELL (2005)

Add to Collection
Article Oncology

The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells

YJ Chen et al.

ANTI-CANCER DRUGS (2001)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.